Dark

Check out our Level2View

CVLB
Conversion Labs, Inc. Common Stock
stock NASDAQ

Inactive

Feb 19, 2021

29.40USD+0.307%(+0.09)473,580

Pre-market

0.00USD-100.000%(-29.31)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Feb 22, 2021

03:30AM EST Conversion Labs, Inc.(NASDAQ: CVLB) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, will begin trading at the opening of the market today under its new name, LifeMD, Inc., and Nasdaq ticker symbol, LFMD. The stocks new CUSIP number will be 53216B 104. GlobeNewswire Inc

Feb 17, 2021

09:25AM EST Conversion Labs, Inc.(NASDAQ: CVLB), a leading direct-to-patient telehealth company, has been invited to present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held on February 17-19, 2021. GlobeNewswire Inc

Feb 12, 2021

08:34AM EST Conversion Labs To Change Name To Life MD, Launches New Concierge Telehealth Services Benzinga

08:30AM EST Conversion Labs, Inc.(NASDAQ: CVLB), a leading direct-to-patient telehealth company, will change its name to Life MD on February 22, followed by the official launch of its subscription-based primary care and concierge services offering designed to positively transform all aspects of a patients healthcare. GlobeNewswire Inc

Feb 5, 2021

10:03AM EST Benzinga's Top Ratings Upgrades, Downgrades For February 5, 2021 Benzinga

08:33AM EST Conversion Labs Appoints Marc Benathen As Chief Financial Officer Benzinga

08:31AM EST Conversion Labs, Inc.(NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has appointed Marc Benathen as chief financial officer, effective March 1. He succeeds Juan Manuel Pieiro Dagnery, who will continue as chief revenue officer. GlobeNewswire Inc

07:01AM EST B. Riley FBR Initiates Coverage On Conversion Labs with Buy Rating, Announces Price Target of $35 Benzinga

Feb 1, 2021

04:03PM EST Why Conversion Labs Stock Is Trading Higher Today Benzinga

Jan 28, 2021

10:37AM EST Conversion Labs Reports Increased Stake In LegalSimpli Software Subsidiary From 51% To 82.6% Benzinga

10:30AM EST Conversion Labs, Inc.(NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has increased its stake in its legacy LegalSimpli Software subsidiary from 51% to 82.6%, largely from the conversion of long-term debt held by Conversion Labs into equity. GlobeNewswire Inc

Jan 19, 2021

08:46AM EST Conversion Labs Sees Q4 Sales ~$13.6M vs $11.2M Estimate; FY20 Sales $38M vs $35.6M Est. Benzinga

08:31AM EST Conversion Labs, Inc.(NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, reported preliminary unaudited results for its fourth quarter and full year ended December 31, 2020. GlobeNewswire Inc

Jan 11, 2021

08:42AM EST Conversion Labs Appoints Anthony Puopolo As Chief Medical Officer RTTNews

08:40AM EST Conversion Labs Appoints Dr. Anthony Puopolo as Chief Medical Officer Benzinga

08:31AM EST Conversion Labs, Inc.(NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed licensed personal care and wellness physician and psychiatrist, Dr. Anthony Puopolo, to the new position of chief medical officer. GlobeNewswire Inc

Jan 7, 2021

12:10PM EST Benzinga's Top Upgrades, Downgrades For January 7, 2021 Benzinga

08:14AM EST BTIG Initiates Coverage On Conversion Labs with Buy Rating, Announces Price Target of $15 Benzinga

Jan 6, 2021

04:01PM EST Conversion Labs, Inc.(NASDAQ: CVLB), a direct-to-consumer telemedicine company, has been invited to present at H.C. Wainwrights BioConnect Conference being held virtually on January 11-14, 2021. GlobeNewswire Inc

Jan 5, 2021

10:15AM EST Conversion Labs Appoints Digital Marketing Executive, Bryant GlobeNewswire Inc

Dec 15, 2020

08:36AM EST Conversion Labs Reports Annualized Sales Run-Rate At $53.9M, Up 332% Year Over Year Benzinga

08:31AM EST Conversion Labs, Inc.(NASDAQ: CVLB), a direct-to-consumer telemedicine and wellness company, reported its annualized revenue run-rate reached a record $53.9 million in November, up 332% versus $12.5 million for all of 2019. The run-rate is based on record revenues of $4.5 million for the month, which was up 233% versus November of last year. GlobeNewswire Inc

Dec 11, 2020

08:31AM EST Conversion Labs, Inc.(NASDAQ: CVLB), a direct-to-consumer telemedicine and wellness company, has officially launched its new Veritas MD telehealth platform, opening the door to greater market expansion with a growing portfolio of industry leading, direct-to-consumer pharmacy and wellness brands. GlobeNewswire Inc

Dec 9, 2020

08:46AM EST Conversion Labs Reports Will Uplist To Nasdaq as Of Dec. 10, 2020 Benzinga

08:33AM EST Conversion Labs Approved For Nasdaq Capital Market Listing; Trading To Commence Dec. 10, 2020, Under the Symbol 'CVLB' Benzinga

08:31AM EST Conversion Labs, Inc.(OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has received approval to uplist to the Nasdaq Capital Market. The companys common stock will commence trading on the exchange at the opening of the market tomorrow, December 10, 2020, under the same symbol, CVLB. GlobeNewswire Inc

Nov 20, 2020

07:31AM EST Conversion Labs, Inc.(OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed expert Life Sciences attorney, Eric H. Yecies, to the new position of chief compliance officer and general counsel. GlobeNewswire Inc

Nov 16, 2020

04:01PM EST Conversion Labs Q3 2020 Revenue up 252% to Record $11.0 Million GlobeNewswire Inc

Nov 10, 2020

07:31AM EST Conversion Labs, Inc.(OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has appointed Roberto Simon to its board of directors and as the chair of its audit committee. Following his appointment, the board now has eight members, with six serving as independent directors. GlobeNewswire Inc

Nov 9, 2020

01:00PM EST Conversion Labs, Inc.(OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, will hold a conference call on Monday, November 16, 2020 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2020. The financial results will be issued in a press release prior to the call. GlobeNewswire Inc

Nov 4, 2020

09:00AM EST Conversion Labs, Inc.(OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has closed on approximately $14.5 million of a $15 million private placement with institutional investors at a purchase price of $4.75 per share. A second closing of an additional $500,000 is expected within the next seven days. GlobeNewswire Inc

Oct 26, 2020

07:35AM EDT Conversion Labs, Inc.(OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has signed a licensing agreement with Restorsea, a leading medical grade skincare technology platform. GlobeNewswire Inc

Oct 21, 2020

07:35AM EDT Conversion Labs, Inc.(OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed healthcare veteran, Dr. Connie Mariano, to its board of directors. Following her appointment, the board will have eight members, with five serving independently. GlobeNewswire Inc

Oct 14, 2020

07:35AM EDT Conversion Labs, Inc.(OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, will effect a 1-for-5 reverse split of its common stock effective prior to the opening of the market today, Wednesday, October 14, 2020. GlobeNewswire Inc

Oct 12, 2020

07:35AM EDT Conversion Labs, Inc.(OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited results for its third quarter ended September 30, 2020. GlobeNewswire Inc

Sep 16, 2020

07:35AM EDT Conversion Labs Closes $3.5 Million Equity Investment, Submits GlobeNewswire Inc

Sep 11, 2020

07:35AM EDT Conversion Labs, Inc.(OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has reported record revenues of $3.7 million for the month of August, up more than 267% versus August 2019. GlobeNewswire Inc

Aug 31, 2020

08:35AM EDT Conversion Labs, Inc.(OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, announced that a select group of private investors and family offices have agreed to purchase $3.5 million of its newly issued Series B Convertible Preferred Stock. GlobeNewswire Inc

Aug 19, 2020

11:45AM EDT Insider Buys Conversion Labs Shares Benzinga

Aug 17, 2020

10:18AM EDT Conversion Labs Q2 2020 Revenue up 237% to Record $9.1 Million; GlobeNewswire Inc

Aug 3, 2020

08:31AM EDT Conversion Labs, Inc.(OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported record revenues of $3.6 million in the month of July, up more than 302% versus July 2019. GlobeNewswire Inc

Jul 29, 2020

08:31AM EDT Conversion Labs, Inc.(OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, will hold a conference call on Monday, August 17, 2020 at 1:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2020. The financial results will be issued in a press release prior to the call. GlobeNewswire Inc

Jul 16, 2020

08:09AM EDT Labs, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire

Share